The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Daiichi Sankyo; GlycoMimetics; Merck
Other Relationship - Celgene; GlycoMimetics
Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
 
Sylvia Adams
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst)
 
Megan Othus
No Relationships to Disclose
 
Sandip Pravin Patel
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Compugen; Illumina; Lilly; Nektar; Novartis
Speakers' Bureau - Boehringer Ingelheim; Merck
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health; Hanmi; Immuneoncia; Lilly; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; Genentech/Roche; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
Travel, Accommodations, Expenses - Hanmi
 
Kathy Miller
Consulting or Advisory Role - Merck; Nektar
Research Funding - Medivation (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Rashmi Chugh
Consulting or Advisory Role - Immune Design
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Epizyme (Inst); Lilly (Inst); MabVax (Inst); Morphotek (Inst); Mundipharma (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
Scott Schuetze
Research Funding - Adaptimmune (Inst); Amgen (Inst); Blueprint Medicines (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Blueprint Medicines
 
Elad Sharon
No Relationships to Disclose
 
Larissa A. Korde
No Relationships to Disclose
 
Robert James Gray
Research Funding - Abbvie; Agios; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Genomic Health; Genzyme; GlaxoSmithKline; Janssen-Ortho; Merck Sharp & Dohme; Novartis; Onyx; Pfizer; Sanofi; Sequenta; Syndax; Takeda
 
Edward Mayerson
No Relationships to Disclose
 
Melissa Plets
No Relationships to Disclose
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; IDbyDNA; Soluventis
Honoraria - AACR; Advanced Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; LEK; NeoGenomics Laboratories; NeoMed; Roche; Wiley
Consulting or Advisory Role - Actuate Therapeutics; Gaido; Loxo; Merck; NeoMed; Pfizer; Roche; Soluventis; XBiotech
Speakers' Bureau - Roche
Research Funding - Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst)
Travel, Accommodations, Expenses - AACR; Advanced Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; LEK; NeoGenomics Laboratories; NeoMed; Roche; Wiley